Pensions & Investments Logo
ETF Exchange > PBE ETF

PBE - ETF Fact Sheet

Invesco Dynamic Biotechnology & Genome ETF - USD

Fund Identification

Ticker

PBE

ISIN

US46137V7872

Main Metrics

Price

$76.26

Expense Ratio

0.58%

AuM

$240.98M

Tracking Difference

-0.60%

Ratings

Trackinsight rating

N/A

ESG Consensus®

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise

Official Investment Strategy

The Invesco Dynamic Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex℠ Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

PBE's historical prices, performance, and flows

-6.0-4.0-2.00.0%
1m returns
-6.83%
1m flows
-$3M
* Net total returns
All data as of 12 March 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all PBE data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

PBE's characteristics

Manager

Manager statistics

631 funds, $977.64Bn in AUM

Benchmark

Dynamic Biotech & Genome Intellidex TR Index - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing

Meets ESG criteria

No
PBE's exposure

Countries

USA
94.25%

Sectors

Health Care
96.95%

Top 5 holdings

ILLUMINA
5.91%
GILEAD SCIENCES
5.35%
AMGEN-T
5.09%
REGENERON PHARMACEUTICALS
4.87%
UTD THERAPEUT
4.83%
Total holdings
30
Total weight of top 5
26.05%
0.0%